Targeted depalmitoylation for the treatment of nras-driven melanoma
Ended Project Grant Awarded Last action
- Award ID
- R43CA250702
- Recipient
-
Palm Therapeutics, Inc. UEI RXJNLF4A6MB8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $857,756
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding
-
- $734,033.88 Federal
- $123,722.00 Non-federal
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$36,298 | $0 | |
| Amendment | -$61,500 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $61,500 | $0 | |
| Amendment | $61,500 | $0 | |
| Amendment | $61,500 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $123,722 | $0 | |
| Amendment | $123,722 | $123,722 | |
| Original award | $399,888 | $0 |
Show all 15
Quick answers
Who received award R43CA250702?
R43CA250702 was awarded to Palm Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2020.
How much is award R43CA250702 worth?
$857,756 has been obligated on R43CA250702: $734,034 in federal funding and $123,722 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award